Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, October 5 2015 12:13am ET - U.S. Markets open in 9 hours and 17 minutes.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Manufacturers - Major News
Latest News
Sunday, Oct 4, 2015
·Johnson & Johnson Announces Completion of Cordis Divestiture to Cardinal Health
PR Newswire - Sun 7:00 pm ET
·Kidney Cancer Drug Boxing Match
at Motley Fool - Sun 1:20 pm ET
·3 Rock-Solid Dividend Stocks You Can Buy Right Now
at Motley Fool - Sun 10:01 am ET
Friday, Oct 2, 2015
·Drug pricing controversy lights up California ballot measure
at - Fri Oct 2
·FDA Approves Merck's Keytruda for Lung Cancer
at The Wall Street Journal Online - Fri Oct 2
·FDA expands Merck drug's approval to treat lung cancer
AP - Fri Oct 2
·U.S. FDA expands approval of Merck's Keytruda to lung cancer
Reuters - Fri Oct 2
·FDA Approves KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression On or After Platinum-Containing Chemotherapy
Business Wire - Fri Oct 2
·FDA approves Merck's Keytruda for use in lung cancer
Reuters - Fri Oct 2
·Bristol-Myers and Celgene Boost Top Ten Stocks’ Performance
- Fri Oct 2
·Amgen Is In Novartis' Crosshair
at Motley Fool - Fri Oct 2
·Why UPS and FedEx may matter to your health
at CNBC - Fri Oct 2
·Skystar Bio-Pharmaceutical Company Provides Investor Update Regarding Delay in Filing Form 10-K
Marketwire - Fri Oct 2
·Market In Re-Test, Ralph Lauren Steps Up, And A Drug For Obscure Disease
at - Fri Oct 2
·Aoxing Pharma to Announce Fiscal 2015 Financial Results, Host Webcast and Conference Call Oct. 13 at 8:30 AM Eastern
- Fri Oct 2
·Pfizer Inc. Announces Final Results of Exchange Offers
Business Wire - Fri Oct 2
Thursday, Oct 1, 2015
·Technically talented lawyers are increasingly valued
at - Thu Oct 1
·Immune Pharmaceuticals Receives Second Tranche of $3 Million from Discover Growth Fund
PR Newswire - Thu Oct 1
·Bristol-Myers' gets early approval of combo cancer treatment
AP - Thu Oct 1
·FDA Approves Two-Drug Therapy for Melanoma
at The Wall Street Journal Online - Thu Oct 1
More Latest News...

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?